Responses of myocardial ischemia to escitalopram treatment (REMIT trial)

Trial Profile

Responses of myocardial ischemia to escitalopram treatment (REMIT trial)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders
  • Focus Pharmacodynamics
  • Acronyms REMIT
  • Most Recent Events

    • 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 01 Apr 2015 Results published in the American Heart Journal.
    • 21 Mar 2014 Planned End Date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top